The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Olanzapine and Fluoxetine · OLANZAPINE 12 mg/1; FLUOXETINE HYDROCHLORIDE 25 mg/1 · Capsule · Oral · AvKARE
NDC 42291-0655-30 · 30 CAPSULE in 1 BOTTLE · ANDA · View full market →
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| AvKARE | OLANZAPINE 12 mg/1; FLUOXETINE HYDROCHLORIDE 50 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| AvKARE | OLANZAPINE 6 mg/1; FLUOXETINE HYDROCHLORIDE 50 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| AvKARE | OLANZAPINE 6 mg/1; FLUOXETINE HYDROCHLORIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| AvKARE | OLANZAPINE 3 mg/1; FLUOXETINE HYDROCHLORIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| AvKARE | OLANZAPINE 12 mg/1; FLUOXETINE HYDROCHLORIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | OLANZAPINE 6 mg/1; FLUOXETINE HYDROCHLORIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | OLANZAPINE 12 mg/1; FLUOXETINE HYDROCHLORIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | OLANZAPINE 12 mg/1; FLUOXETINE HYDROCHLORIDE 50 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | OLANZAPINE 6 mg/1; FLUOXETINE HYDROCHLORIDE 50 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | OLANZAPINE 3 mg/1; FLUOXETINE HYDROCHLORIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| AvKARE | OLANZAPINE 25 mg/1; FLUOXETINE HYDROCHLORIDE 12 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| AvKARE | OLANZAPINE 50 mg/1; FLUOXETINE HYDROCHLORIDE 6 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| AvKARE | OLANZAPINE 50 mg/1; FLUOXETINE HYDROCHLORIDE 12 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| AvKARE | OLANZAPINE 25 mg/1; FLUOXETINE HYDROCHLORIDE 6 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| AvKARE | OLANZAPINE 25 mg/1; FLUOXETINE HYDROCHLORIDE 3 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Teva Pharmaceuticals USA, Inc. | OLANZAPINE 25 mg/1; FLUOXETINE HYDROCHLORIDE 12 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Teva Pharmaceuticals USA, Inc. | OLANZAPINE 25 mg/1; FLUOXETINE HYDROCHLORIDE 3 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Teva Pharmaceuticals USA, Inc. | OLANZAPINE 25 mg/1; FLUOXETINE HYDROCHLORIDE 6 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Teva Pharmaceuticals USA, Inc. | OLANZAPINE 50 mg/1; FLUOXETINE HYDROCHLORIDE 12 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Teva Pharmaceuticals USA, Inc. | OLANZAPINE 50 mg/1; FLUOXETINE HYDROCHLORIDE 6 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| AvKARE | FLUOXETINE HYDROCHLORIDE 50 mg/1; OLANZAPINE 12 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| AvKARE | FLUOXETINE HYDROCHLORIDE 25 mg/1; OLANZAPINE 12 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| AvKARE | FLUOXETINE HYDROCHLORIDE 25 mg/1; OLANZAPINE 6 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| AvKARE | FLUOXETINE HYDROCHLORIDE 25 mg/1; OLANZAPINE 3 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| AvKARE | FLUOXETINE HYDROCHLORIDE 50 mg/1; OLANZAPINE 6 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Teva Pharmaceuticals USA, Inc. | FLUOXETINE HYDROCHLORIDE 25 mg/1; OLANZAPINE 3 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Teva Pharmaceuticals USA, Inc. | FLUOXETINE HYDROCHLORIDE 50 mg/1; OLANZAPINE 12 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Teva Pharmaceuticals USA, Inc. | FLUOXETINE HYDROCHLORIDE 25 mg/1; OLANZAPINE 6 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Teva Pharmaceuticals USA, Inc. | FLUOXETINE HYDROCHLORIDE 25 mg/1; OLANZAPINE 12 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Teva Pharmaceuticals USA, Inc. | FLUOXETINE HYDROCHLORIDE 50 mg/1; OLANZAPINE 6 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Olanzapine and Fluoxetine — NDC 42291-0655-30," retrieved September 3, 2026, https://drugdashboards.com/drug/42291065530.
Free to cite with attribution — see how the data is put together.